TY - JOUR
T1 - Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients
T2 - Effect of inflammatory cytokines
AU - Pankajakshan, Divya
AU - Jia, Guanghong
AU - Pipinos, Iraklis
AU - Tyndall, Steve H.
AU - Agrawal, Devendra K.
N1 - Funding Information:
This work was supported by the National Institutes of Health Grant R01 HL073349 to D.K.A.
PY - 2011/6
Y1 - 2011/6
N2 - Aims: Cytokines released by the immune cells at the site of plaque milieu induce smooth muscle cell apoptosis to promote plaque instability. But, neuropeptide Y (NPY), a pleotropic factor, may modulate the effects of cytokines in atherosclerotic plaques of patients with carotid stenosis. Our aim was to investigate the relative expression of NPY-Y1, NPY-Y2 and NPY-Y5 receptors on carotid plaque vascular smooth muscle cells (pVSMCs) of symptomatic (S) and asymptomatic (AS) patients and examine the effect of inflammatory cytokines on the expression of NPY receptors, that may attenuate plaque rupture. Methods and results: In healthy carotid artery, there were significantly increased immunopositivity and increased mRNA transcripts of NPY-Y1 and NPY-Y5 receptors in thin sections and isolated VSMCs, respectively, compared to S and AS plaques. However, the NPY-Y2 expression was higher in S and AS pVSMCs than controls. Stimulation of the cells with TNF-Α, IL-12 or IFN-Γ (50. ng/ml) decreased mRNA transcripts of NPY-Y1 and NPY-Y5 and increased NPY-Y2 mRNAs in VSMCs of healthy carotid artery. The effect of the cytokines on mRNA transcripts of NPY-Y5 and NPY-Y2 in pVSMCs of S and AS patients was similar to healthy VSMCs, but with variable effect on NPY-Y1. Conclusion: Increased expression of NPY-Y2 receptors in symptomatic pVSMCs than in healthy and asymptomatic subjects suggests a potential role of NPY-Y2 in plaque instability. This is further supported by the pronounced effect of atheroma-associated cytokines to increase NPY-Y2 mRNA transcripts in pVSMCs of patients with carotid stenosis.
AB - Aims: Cytokines released by the immune cells at the site of plaque milieu induce smooth muscle cell apoptosis to promote plaque instability. But, neuropeptide Y (NPY), a pleotropic factor, may modulate the effects of cytokines in atherosclerotic plaques of patients with carotid stenosis. Our aim was to investigate the relative expression of NPY-Y1, NPY-Y2 and NPY-Y5 receptors on carotid plaque vascular smooth muscle cells (pVSMCs) of symptomatic (S) and asymptomatic (AS) patients and examine the effect of inflammatory cytokines on the expression of NPY receptors, that may attenuate plaque rupture. Methods and results: In healthy carotid artery, there were significantly increased immunopositivity and increased mRNA transcripts of NPY-Y1 and NPY-Y5 receptors in thin sections and isolated VSMCs, respectively, compared to S and AS plaques. However, the NPY-Y2 expression was higher in S and AS pVSMCs than controls. Stimulation of the cells with TNF-Α, IL-12 or IFN-Γ (50. ng/ml) decreased mRNA transcripts of NPY-Y1 and NPY-Y5 and increased NPY-Y2 mRNAs in VSMCs of healthy carotid artery. The effect of the cytokines on mRNA transcripts of NPY-Y5 and NPY-Y2 in pVSMCs of S and AS patients was similar to healthy VSMCs, but with variable effect on NPY-Y1. Conclusion: Increased expression of NPY-Y2 receptors in symptomatic pVSMCs than in healthy and asymptomatic subjects suggests a potential role of NPY-Y2 in plaque instability. This is further supported by the pronounced effect of atheroma-associated cytokines to increase NPY-Y2 mRNA transcripts in pVSMCs of patients with carotid stenosis.
KW - Atheromatous cytokines
KW - Atherosclerosis
KW - Carotid plaque
KW - Carotid stenosis
KW - Neuropeptide Y
KW - Smooth muscle cells
UR - http://www.scopus.com/inward/record.url?scp=79952707522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952707522&partnerID=8YFLogxK
U2 - 10.1016/j.yexmp.2011.02.005
DO - 10.1016/j.yexmp.2011.02.005
M3 - Article
C2 - 21352822
AN - SCOPUS:79952707522
SN - 0014-4800
VL - 90
SP - 280
EP - 286
JO - Experimental and Molecular Pathology
JF - Experimental and Molecular Pathology
IS - 3
ER -